ABSORICA LD

Serial Number 88173525
Registration 6038031
700

Registration Progress

Application Filed
Oct 29, 2018
Under Examination
Jun 4, 2019
Approved for Publication
Apr 9, 2019
Published for Opposition
Apr 9, 2019
Registered
Apr 21, 2020

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2020-04-21)
Due: Apr 21, 2026 258 days

Trademark Image

ABSORICA LD

Basic Information

Serial Number
88173525
Registration Number
6038031
Filing Date
October 29, 2018
Registration Date
April 21, 2020
Published for Opposition
April 9, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 21, 2020
Registration
Registered
Classes
005

Rights Holder

SUN PHARMACEUTICAL INDUSTRIES, INC.

03
Address
2 INDEPENDENCE WAY
PRINCETON, NJ 08540

Ownership History

Sun Pharmaceutical Industries, Inc.

Original Applicant
03
Princeton, NJ

Sun Pharmaceutical Industries, Inc.

Owner at Publication
03
Princeton, NJ

Sun Pharmaceutical Industries, Inc.

Original Registrant
03
Princeton, NJ

SUN PHARMACEUTICAL INDUSTRIES, INC.

New Owner After Registration #1
03
PRINCETON, NJ

Legal Representation

Attorney
Craig Kuchii, Esq.

USPTO Deadlines

Next Deadline
258 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-04-21)
Due Date
April 21, 2026
Grace Period Ends
October 21, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

26 events
Date Code Type Description Documents
Apr 21, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Aug 25, 2021 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Apr 21, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 17, 2020 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Mar 16, 2020 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Feb 25, 2020 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Feb 25, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 5, 2020 IUAF S USE AMENDMENT FILED Loading...
Feb 5, 2020 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Nov 27, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 25, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 25, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 25, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 4, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 9, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 9, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 20, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 25, 2019 ALIE A ASSIGNED TO LIE Loading...
Feb 9, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 8, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 8, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 8, 2019 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Feb 8, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Feb 4, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 13, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 1, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical and medicinal preparation for treatment of dermatological conditions
First Use Anywhere: Jan 27, 2020
First Use in Commerce: Jan 27, 2020

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"LD"